povidone-iodine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
radiopharmaceuticals, iodine-contained 4249 25655-41-8

Description:

MoleculeDescription

Synonyms:

  • povidone-iodine
  • povidone iodine
  • iodine-povidone complex
  • iodovidone
  • proviodine
An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.
  • Molecular weight:
  • Formula: I2(C6H9NO)n
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
0.20 g V

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
Nov. 29, 1985 FDA BECTON DICKINSON

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxic anterior segment syndrome 812.93 17.70 157 13069 2093 90613128
Endophthalmitis 698.14 17.70 157 13069 4528 90610693
Hypopyon 234.73 17.70 48 13178 866 90614355
Corneal oedema 174.21 17.70 43 13183 1858 90613363
Visual acuity reduced 157.19 17.70 74 13152 23336 90591885
Drug hypersensitivity 128.86 17.70 237 12989 463372 90151849
Anterior chamber cell 127.91 17.70 28 13198 708 90614513
Vitritis 115.68 17.70 30 13196 1584 90613637
Tonsillar ulcer 113.61 17.70 22 13204 296 90614925
Aqueous fibrin 106.42 17.70 18 13208 105 90615116
Retinopathy of prematurity 104.08 17.70 21 13205 353 90614868
Eye pain 103.55 17.70 70 13156 44098 90571123
Onychomadesis 96.31 17.70 68 13158 45930 90569291
Anterior chamber fibrin 91.11 17.70 16 13210 120 90615101
Lower respiratory tract infection viral 89.13 17.70 22 13204 950 90614271
Onychomycosis 84.67 17.70 58 13168 37318 90577903
Nail bed inflammation 84.63 17.70 24 13202 1777 90613444
Bacterial endophthalmitis 84.09 17.70 16 13210 195 90615026
Streptococcal sepsis 84 17.70 28 13198 3556 90611665
Nasal mucosal disorder 79.44 17.70 23 13203 1834 90613387
Eye inflammation 79.08 17.70 33 13193 7818 90607403
Pseudomonal sepsis 78.99 17.70 28 13198 4274 90610947
C-reactive protein increased 76.30 17.70 112 13114 181277 90433944
Intraocular pressure increased 72.07 17.70 30 13196 7063 90608158
Lip ulceration 71.22 17.70 22 13204 2190 90613031
Corneal epithelium defect 65.24 17.70 15 13211 476 90614745
Conjunctival oedema 64.57 17.70 17 13209 952 90614269
Oliguria 60.46 17.70 30 13196 10594 90604627
Punctate keratitis 58.04 17.70 15 13211 781 90614440
Metastases to lymph nodes 57.75 17.70 30 13196 11659 90603562
Hepatic enzyme 55.63 17.70 23 13203 5321 90609900
Post procedural discomfort 54.67 17.70 16 13210 1325 90613896
Vascular device infection 54.29 17.70 29 13197 11923 90603298
Macular oedema 54.07 17.70 22 13204 4887 90610334
Paronychia 52.77 17.70 25 13201 7981 90607240
Parophthalmia 51.31 17.70 12 13214 411 90614810
Vitreous floaters 51.07 17.70 24 13202 7525 90607696
Ocular hyperaemia 50.81 17.70 41 13185 33757 90581464
Tonsillitis 49.76 17.70 23 13203 6946 90608275
Varicose vein 48.66 17.70 23 13203 7304 90607917
Injection site reaction 46.33 17.70 62 13164 92018 90523203
Type 2 diabetes mellitus 45.41 17.70 95 13131 203149 90412072
Metamorphopsia 44.84 17.70 14 13212 1443 90613778
Cataract nuclear 44.36 17.70 13 13213 1081 90614140
Brain oedema 41.80 17.70 28 13198 17357 90597864
Retinal haemorrhage 41.08 17.70 19 13207 5745 90609476
Candida infection 40.29 17.70 36 13190 34021 90581200
Psoriatic arthropathy 39.05 17.70 96 13130 228239 90386982
Corneal abrasion 37.82 17.70 12 13214 1304 90613917
Product use in unapproved indication 37.48 17.70 121 13105 336115 90279106
Suspected transmission of an infectious agent via product 36.29 17.70 9 13217 396 90614825
Foetal non-stress test abnormal 35.62 17.70 6 13220 34 90615187
Product contamination microbial 34.09 17.70 8 13218 278 90614943
Vision blurred 33.81 17.70 59 13167 110234 90504987
Blepharospasm 33.67 17.70 41 13185 55404 90559817
Corneal infiltrates 32.48 17.70 7 13219 164 90615057
Metastases to central nervous system 32.29 17.70 24 13202 17518 90597703
Epilepsy 32 17.70 49 13177 82157 90533064
Restlessness 31.31 17.70 32 13194 35688 90579533
Procedural pain 31.28 17.70 31 13195 33329 90581892
Off label use 31.15 17.70 270 12956 1101982 89513239
Vitreous detachment 30.87 17.70 12 13214 2366 90612855
Polyglandular disorder 30.30 17.70 7 13219 227 90614994
Rheumatic fever 30.10 17.70 68 13158 153053 90462168
Pericarditis 28.98 17.70 96 13130 270055 90345166
Ophthalmological examination abnormal 28.75 17.70 6 13220 120 90615101
Cystoid macular oedema 28.70 17.70 11 13215 2089 90613132
Non-infectious endophthalmitis 28.43 17.70 7 13219 299 90614922
Underdose 28.13 17.70 37 13189 53980 90561241
C-reactive protein abnormal 27.78 17.70 59 13167 127370 90487851
Anterior chamber disorder 27.59 17.70 6 13220 147 90615074
Blindness unilateral 27.56 17.70 16 13210 7720 90607501
Retinal scar 27.28 17.70 6 13220 155 90615066
Eczema 27.20 17.70 36 13190 52834 90562387
Cataract operation complication 26.92 17.70 6 13220 165 90615056
Toxicity to various agents 26.42 17.70 5 13221 287841 90327380
Vitreous haemorrhage 26.32 17.70 11 13215 2615 90612606
Visual impairment 26.25 17.70 59 13167 132306 90482915
Retinal disorder 26.04 17.70 10 13216 1909 90613312
Eye oedema 25.87 17.70 10 13216 1942 90613279
Sleep disorder 25.50 17.70 75 13151 197955 90417266
Conjunctivitis 25.38 17.70 25 13201 26681 90588540
Drug interaction 24.95 17.70 5 13221 276448 90338773
Anaemia folate deficiency 24.41 17.70 7 13219 539 90614682
Retinal pigment epithelial tear 24.17 17.70 6 13220 265 90614956
Retinal oedema 23.61 17.70 8 13218 1068 90614153
Exophthalmos 23.06 17.70 9 13217 1793 90613428
Taste disorder 22.99 17.70 36 13190 61510 90553711
Multiple use of single-use product 22.96 17.70 9 13217 1814 90613407
Transmission of an infectious agent via product 22.31 17.70 5 13221 141 90615080
Delayed delivery 22.03 17.70 4 13222 37 90615184
Blepharitis 21.95 17.70 11 13215 3965 90611256
Eyelid oedema 21.72 17.70 16 13210 11518 90603703
Product dose omission issue 21.24 17.70 8 13218 291679 90323542
Conjunctival hyperaemia 21.20 17.70 10 13216 3159 90612062
Dermatitis exfoliative generalised 21.08 17.70 12 13214 5581 90609640
Corneal opacity 20.88 17.70 7 13219 904 90614317
Genital haemorrhage 20.88 17.70 14 13212 8688 90606533
Foreign body sensation in eyes 20.82 17.70 10 13216 3290 90611931
Anaphylactic reaction 20.80 17.70 42 13184 87482 90527739
Enterocutaneous fistula 20.64 17.70 8 13218 1566 90613655
Intentional product use issue 20.57 17.70 74 13152 216818 90398403
Endocrine disorder 20.52 17.70 7 13219 953 90614268
Eye irritation 20.42 17.70 25 13201 33953 90581268
Post procedural complication 20.31 17.70 19 13207 19023 90596198
Hypoparathyroidism 20.23 17.70 7 13219 994 90614227
Iridocyclitis 19.83 17.70 10 13216 3651 90611570
Ocular toxicity 19.73 17.70 7 13219 1070 90614151
Wound 19.71 17.70 92 13134 302888 90312333
Photopsia 19.53 17.70 11 13215 5013 90610208
Chronic hepatitis 19.31 17.70 7 13219 1138 90614083
Therapeutic product effect incomplete 19.10 17.70 67 13159 193829 90421392
Retinal cyst 18.43 17.70 4 13222 97 90615124
Chest pain 18.40 17.70 12 13214 319633 90295588
Procedural haemorrhage 18.30 17.70 9 13217 3115 90612106
Breast cancer stage III 18.28 17.70 39 13187 84408 90530813
Lacrimation increased 18.05 17.70 21 13205 27041 90588180

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Endophthalmitis 531.72 25.14 113 3571 4320 42613331
Toxic anterior segment syndrome 472.28 25.14 85 3599 1331 42616320
Hypopyon 151.52 25.14 28 3656 507 42617144
Visual acuity reduced 148.01 25.14 56 3628 17494 42600157
Corneal oedema 138.07 25.14 31 3653 1517 42616134
Retinopathy of prematurity 128.97 25.14 21 3663 172 42617479
Eye pain 110.63 25.14 45 3639 16985 42600666
Vitritis 105.88 25.14 24 3660 1225 42616426
Vision blurred 98.62 25.14 60 3624 53639 42564012
Anterior chamber cell 97.98 25.14 19 3665 449 42617202
Vitreous floaters 93.94 25.14 28 3656 4202 42613449
Eye inflammation 78.90 25.14 23 3661 3195 42614456
Anterior chamber fibrin 66.18 25.14 10 3674 47 42617604
Aqueous fibrin 62.18 25.14 10 3674 75 42617576
Bacterial endophthalmitis 58.17 25.14 10 3674 117 42617534
Non-infectious endophthalmitis 56.87 25.14 11 3673 256 42617395
Ocular hyperaemia 54.77 25.14 27 3657 15936 42601715
Anaphylactic reaction 54.42 25.14 38 3646 42705 42574946
Blindness 51.73 25.14 27 3657 17951 42599700
Visual impairment 49.52 25.14 36 3648 43077 42574574
Anaphylactic shock 42.38 25.14 26 3658 23491 42594160
Vitreous disorder 36.19 25.14 7 3677 163 42617488
Macular oedema 35.96 25.14 13 3671 3556 42614095
Eye irritation 35.44 25.14 18 3666 11300 42606351
Off label use 33.92 25.14 126 3558 638209 41979442
Pseudoendophthalmitis 33.84 25.14 6 3678 85 42617566
Anterior chamber flare 33.51 25.14 6 3678 90 42617561
Eye oedema 33.49 25.14 9 3675 928 42616723
Vitreous detachment 32.77 25.14 9 3675 1007 42616644
Metamorphopsia 31.99 25.14 8 3676 621 42617030
Retinal pigment epithelial tear 31.47 25.14 7 3677 327 42617324
Urine iodine increased 30.18 25.14 4 3680 5 42617646
Pathogen resistance 29.55 25.14 16 3668 11434 42606217
Diabetic retinal oedema 28.23 25.14 6 3678 226 42617425
Haemorrhoids thrombosed 27.19 25.14 6 3678 270 42617381
Toxic skin eruption 26.84 25.14 16 3668 13714 42603937
Retinal haemorrhage 26.68 25.14 12 3672 5758 42611893
Eye infection bacterial 26.34 25.14 5 3679 105 42617546
Conjunctival hyperaemia 26.24 25.14 10 3674 3166 42614485
Facial paresis 26.02 25.14 10 3674 3240 42614411
Macular fibrosis 25.19 25.14 6 3678 380 42617271

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxic anterior segment syndrome 1196.25 17.98 231 15251 3223 110570594
Endophthalmitis 1067.09 17.98 244 15238 7943 110565874
Hypopyon 334.01 17.98 69 15413 1371 110572446
Corneal oedema 284.80 17.98 70 15412 3103 110570714
Visual acuity reduced 233.63 17.98 106 15376 32067 110541750
Anterior chamber cell 217.22 17.98 47 15435 1174 110572643
Vitritis 205.43 17.98 52 15430 2601 110571216
Aqueous fibrin 149.97 17.98 26 15456 188 110573629
Anterior chamber fibrin 145.93 17.98 26 15456 224 110573593
Bacterial endophthalmitis 131.52 17.98 25 15457 317 110573500
Eye pain 119.49 17.98 79 15403 50020 110523797
Tonsillar ulcer 105.90 17.98 22 15460 449 110573368
Eye inflammation 105.82 17.98 42 15440 9129 110564688
Onychomadesis 101.67 17.98 69 15413 45594 110528223
Onychomycosis 90.03 17.98 60 15422 38471 110535346
Drug hypersensitivity 89.97 17.98 197 15285 453893 110119924
Nail bed inflammation 87.23 17.98 25 15457 2005 110571812
Nasal mucosal disorder 84.55 17.98 24 15458 1859 110571958
Non-infectious endophthalmitis 82.30 17.98 18 15464 473 110573344
Lower respiratory tract infection viral 81.44 17.98 22 15460 1419 110572398
C-reactive protein increased 77.88 17.98 122 15360 217797 110356020
Ocular hyperaemia 77.22 17.98 55 15427 39231 110534586
Punctate keratitis 75.71 17.98 20 15462 1184 110572633
Streptococcal sepsis 75.62 17.98 28 15454 5044 110568773
Intraocular pressure increased 73.16 17.98 34 15448 10842 110562975
Vitreous floaters 72.35 17.98 32 15450 9102 110564715
Lip ulceration 67.18 17.98 22 15460 2756 110571061
Corneal epithelium defect 66.29 17.98 17 15465 895 110572922
Suspected transmission of an infectious agent via product 63.57 17.98 18 15464 1382 110572435
Vision blurred 63.31 17.98 84 15398 128938 110444879
Pseudomonal sepsis 63.09 17.98 29 15453 9017 110564800
Hepatic enzyme 57.32 17.98 23 15459 5140 110568677
Anaphylactic reaction 55.43 17.98 74 15408 114226 110459591
Retinal pigment epithelial tear 54.99 17.98 13 15469 487 110573330
Metastases to lymph nodes 54.52 17.98 31 15451 15001 110558816
Varicose vein 53.95 17.98 24 15458 6916 110566901
Macular oedema 53.87 17.98 24 15458 6942 110566875
Corneal infiltrates 53.53 17.98 12 15470 354 110573463
Injection site reaction 53.23 17.98 64 15418 89006 110484811
Post procedural discomfort 52.59 17.98 15 15467 1182 110572635
Type 2 diabetes mellitus 52.21 17.98 91 15391 177141 110396676
Off label use 51.55 17.98 372 15110 1499813 109074004
Vascular device infection 49.23 17.98 30 15452 16482 110557335
Paronychia 48.87 17.98 26 15456 11055 110562762
Conjunctival oedema 48.71 17.98 15 15467 1541 110572276
Metamorphopsia 47.99 17.98 15 15467 1618 110572199
Candida infection 47.33 17.98 45 15437 47964 110525853
Tonsillitis 47.07 17.98 23 15459 8190 110565627
Psoriatic arthropathy 45.42 17.98 91 15391 196670 110377147
Drug interaction 44.79 17.98 8 15474 500175 110073642
Pseudoendophthalmitis 43.64 17.98 8 15474 82 110573735
Transmission of an infectious agent via product 42.76 17.98 9 15473 196 110573621
Procedural pain 42.22 17.98 37 15445 35528 110538289
Corneal abrasion 41.65 17.98 13 15469 1396 110572421
Rheumatic fever 41.50 17.98 67 15415 122512 110451305
Retinal haemorrhage 41.07 17.98 22 15460 9479 110564338
Oliguria 41.05 17.98 28 15454 18629 110555188
Anaphylactic shock 41.01 17.98 43 15439 51503 110522314
Visual impairment 40.86 17.98 70 15412 134358 110439459
Post procedural complication 40.52 17.98 32 15450 26626 110547191
Parophthalmia 39.00 17.98 10 15472 526 110573291
Toxicity to various agents 38.32 17.98 10 15472 480545 110093272
Ocular toxicity 38.11 17.98 12 15470 1326 110572491
Wound 37.85 17.98 94 15388 234343 110339474
Pericarditis 37.66 17.98 90 15392 219024 110354793
Blepharospasm 37.08 17.98 42 15440 54809 110519008
Anterior chamber flare 36.58 17.98 8 15474 210 110573607
Product contamination microbial 36.17 17.98 11 15471 1083 110572734
Urine iodine increased 35.91 17.98 5 15477 5 110573812
Blindness 35.69 17.98 34 15448 36325 110537492
Ocular hypertension 34.82 17.98 13 15469 2395 110571422
Corneal opacity 34.72 17.98 11 15471 1240 110572577
Eye oedema 34.04 17.98 13 15469 2549 110571268
Pemphigus 33.55 17.98 85 15397 214485 110359332
Vitreous detachment 33.54 17.98 13 15469 2652 110571165
Cataract nuclear 33.46 17.98 11 15471 1395 110572422
Anterior chamber disorder 32.77 17.98 7 15475 164 110573653
Conjunctival hyperaemia 32.43 17.98 16 15466 5815 110568002
Conjunctivitis 32.03 17.98 31 15451 33761 110540056
Vitreous disorder 31.93 17.98 8 15474 383 110573434
Metastases to central nervous system 31.73 17.98 26 15456 22791 110551026
Epilepsy 31.52 17.98 53 15429 100156 110473661
Retinal disorder 31.39 17.98 12 15470 2358 110571459
C-reactive protein abnormal 31.14 17.98 61 15421 129634 110444183
Systemic lupus erythematosus 31.04 17.98 92 15390 254246 110319571
Foreign body sensation in eyes 30.72 17.98 13 15469 3321 110570496
Iridocyclitis 30.56 17.98 15 15467 5393 110568424
Brain oedema 30.37 17.98 29 15453 31069 110542748
Multiple use of single-use product 30.28 17.98 10 15472 1286 110572531
Polyglandular disorder 30.24 17.98 7 15475 239 110573578
Vitreous haemorrhage 29.70 17.98 14 15468 4606 110569211
Cataract operation complication 29.21 17.98 7 15475 278 110573539
Taste disorder 26.71 17.98 39 15443 65348 110508469
Anterior chamber inflammation 26.51 17.98 8 15474 767 110573050
Ill-defined disorder 26.48 17.98 64 15418 156789 110417028
Ophthalmological examination abnormal 26.40 17.98 5 15477 62 110573755
Eye infection bacterial 26.35 17.98 7 15475 423 110573394
Retinal scar 25.61 17.98 7 15475 472 110573345
Vitreous opacities 25.43 17.98 8 15474 881 110572936
Product dose omission issue 25.06 17.98 7 15475 321775 110252042
Blindness unilateral 24.70 17.98 16 15466 9770 110564047
Underdose 24.65 17.98 37 15445 63517 110510300
Keratic precipitates 24.57 17.98 7 15475 549 110573268
Retinal oedema 24.32 17.98 9 15473 1618 110572199
Post procedural infection 24.10 17.98 18 15464 13791 110560026
Delayed delivery 23.86 17.98 4 15478 23 110573794
Toxic skin eruption 23.77 17.98 24 15458 27491 110546326
Genital haemorrhage 23.76 17.98 14 15468 7238 110566579
Restlessness 23.62 17.98 34 15448 56225 110517592
Haemorrhoids thrombosed 23.39 17.98 6 15476 316 110573501
Anaemia folate deficiency 22.97 17.98 7 15475 694 110573123
Cystoid macular oedema 22.79 17.98 10 15472 2790 110571027
Maculopathy 22.04 17.98 10 15472 3017 110570800
Synovitis 21.85 17.98 86 15396 274006 110299811
Eye irritation 21.57 17.98 25 15457 33427 110540390
Exophthalmos 21.40 17.98 9 15473 2264 110571553
Balanitis candida 21.26 17.98 5 15477 183 110573634
Eczema 21.11 17.98 37 15445 72256 110501561
Blepharitis 20.97 17.98 11 15471 4541 110569276
Poor quality product administered 20.77 17.98 11 15471 4630 110569187
Intentional product use issue 20.75 17.98 79 15403 247827 110325990
Sleep disorder 20.66 17.98 68 15414 198576 110375241
Somnolence 20.48 17.98 8 15474 297441 110276376
Photopsia 20.37 17.98 12 15470 6202 110567615
Retinopathy of prematurity 20.33 17.98 3 15479 6 110573811
Breast cancer stage III 19.95 17.98 38 15444 79079 110494738
Lacrimation increased 19.74 17.98 23 15459 30927 110542890
Endocrine disorder 19.73 17.98 7 15475 1117 110572700
Product quality issue 19.33 17.98 37 15445 77262 110496555
Ocular discomfort 19.23 17.98 13 15469 8520 110565297
Cardiac pacemaker removal 19.23 17.98 3 15479 10 110573807
Death 18.77 17.98 44 15438 698825 109874992
Nail disorder 18.69 17.98 31 15451 57904 110515913
Macular fibrosis 18.59 17.98 6 15476 718 110573099
Chemical burn 18.40 17.98 6 15476 742 110573075
Eyelid oedema 18.36 17.98 16 15466 15246 110558571

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D08AG02 DERMATOLOGICALS
ANTISEPTICS AND DISINFECTANTS
ANTISEPTICS AND DISINFECTANTS
Iodine products
ATC D09AA09 DERMATOLOGICALS
MEDICATED DRESSINGS
MEDICATED DRESSINGS
Medicated dressings with antiinfectives
ATC D11AC06 DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
OTHER DERMATOLOGICAL PREPARATIONS
Medicated shampoos
ATC G01AX11 GENITO URINARY SYSTEM AND SEX HORMONES
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
Other antiinfectives and antiseptics
ATC R02AA15 RESPIRATORY SYSTEM
THROAT PREPARATIONS
THROAT PREPARATIONS
Antiseptics
ATC S01AX18 SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIINFECTIVES
Other antiinfectives
FDA CS M0011640 Iodine
FDA EPC N0000175486 Antiseptic
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000891 Anti-Infective Agents, Local
CHEBI has role CHEBI:22587 antiviral agent
CHEBI has role CHEBI:33281 antimicrobial agent
CHEBI has role CHEBI:33282 antibacterial agent
CHEBI has role CHEBI:35441 antiinfective agent
CHEBI has role CHEBI:35610 antineoplastic agent
CHEBI has role CHEBI:50177 dermatologic drug
CHEBI has role CHEBI:66981 ophthalmology drug
CHEBI has role CHEBI:67079 anti-inflammatory agent
CHEBI has role CHEBI:73336 vulnerary

Related Drugs by ATC class:

D08AG Iodine products 2 drugs
diiodohydroxypropaneiodine
D09AA Medicated dressings with antiinfectives 11 drugs
aluminium chlorohydratebenzalkoniumcetylpyridiniumchlorhexidineclioquinolframycetinfusidic acidiodoformnitrofurazonephenylmercuric nitratetriclosan
D11AC Medicated shampoos 2 drugs
cetrimidexenysalate
G01AX Other antiinfectives and antiseptics 10 drugs
ciclopiroxclodantoinfurazolidonehexetidineinosinemethylrosanilinenifurateloctenidinepolicresulenprotiofate
R02AA Antiseptics 15 drugs
ambazonebenzalkoniumbenzethoniumcetrimoniumcetylpyridiniumchlorhexidinechlorquinaldoldequaliniumdichlorobenzyl alcoholeuflavinehexamidinehexylresorcinol show all 15 →
S01AX Other antiinfectives 13 drugs
bibrocatholcethexoniumchlorhexidinedibrompropamidinehexamidinelotilanernitrofurazonepicloxydinepolihexanidepropamidineresorcinolsodium borate show all 13 →

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Bacterial septicemia contraindication 10001005 DOID:0040085
Shock contraindication 27942005
Decreased respiratory function contraindication 80954004
Open wound contraindication 125643001
Seizure disorder contraindication 128613002
Heart block contraindication 233916004
Disease of liver contraindication 235856003 DOID:409
Pregnancy, function contraindication 289908002
Denuded skin contraindication 418242004




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4019273 VUID
N0000147472 NUI
D00863 KEGG_DRUG
4018171 VANDF
4019273 VANDF
C0032857 UMLSCUI
CHEBI:8347 CHEBI
CHEMBL1201724 ChEMBL_ID
D011206 MESH_DESCRIPTOR_UI
DB06812 DRUGBANK_ID
85H0HZU99M UNII
8611 RXNORM
1871 MMSL
5338 MMSL
003153 NDDF
111144003 SNOMEDCT_US
386989006 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Betadine HUMAN PRESCRIPTION DRUG LABEL 1 0065-0411 SOLUTION 5 mg OPHTHALMIC NDA 16 sections
First Aid Antiseptic HUMAN OTC DRUG LABEL 1 0363-0777 SOLUTION 10 mg TOPICAL OTC Monograph Drug 14 sections
Apothecary PVP Topical HUMAN OTC DRUG LABEL 1 0363-0939 SOLUTION 1 g TOPICAL OTC monograph not final 11 sections
Walgreens Antiseptic First aid HUMAN OTC DRUG LABEL 1 0363-3116 SPRAY 5 mg TOPICAL OTC Monograph Drug 12 sections
Walgreens 10 Povidone-Iodine Solution HUMAN OTC DRUG LABEL 1 0363-3736 LIQUID 100 mg TOPICAL OTC Monograph Drug 12 sections
First Aid Antiseptic HUMAN OTC DRUG LABEL 1 0363-6280 SPRAY 5 mg TOPICAL OTC Monograph Drug 14 sections
Humco Povidone Iodine HUMAN OTC DRUG LABEL 1 0395-2325 LIQUID 100 mg TOPICAL OTC Monograph Drug 13 sections
Povidone Iodine HUMAN OTC DRUG LABEL 1 0395-9123 LIQUID 100 mg TOPICAL OTC Monograph Drug 13 sections
Povidone Iodine HUMAN OTC DRUG LABEL 1 0395-9128 LIQUID 5 mg TOPICAL OTC Monograph Drug 14 sections
Povidone Iodine HUMAN OTC DRUG LABEL 1 0395-9129 LIQUID 50 mg TOPICAL OTC Monograph Drug 13 sections
Povidone Iodine HUMAN OTC DRUG LABEL 1 0395-9136 LIQUID 5 mg TOPICAL OTC Monograph Drug 14 sections
Henry Schein Povidone-Iodine Swabsticks HUMAN OTC DRUG LABEL 1 0404-0119 SWAB 1 g TOPICAL OTC Monograph Drug 13 sections
Henry Schein Povidone-Iodine Swabsticks HUMAN OTC DRUG LABEL 1 0404-0120 SWAB 1 g TOPICAL OTC Monograph Drug 13 sections
Henry Schein Povidone-Iodine Prep Pad HUMAN OTC DRUG LABEL 1 0404-0121 SWAB 1 g TOPICAL OTC Monograph Drug 10 sections
povidine iodine HUMAN OTC DRUG LABEL 1 0404-5637 SWAB 10 mL TOPICAL OTC monograph final 11 sections
povidine iodine HUMAN OTC DRUG LABEL 1 0404-5638 SWAB 10 mL TOPICAL OTC monograph final 11 sections
povidine iodine HUMAN OTC DRUG LABEL 1 0404-5639 SWAB 10 mL TOPICAL OTC monograph final 11 sections
First Aid Antiseptic HUMAN OTC DRUG LABEL 1 0536-1271 OINTMENT 100 mg TOPICAL OTC Monograph Drug 13 sections
povidone iodine HUMAN OTC DRUG LABEL 1 0904-1103 SOLUTION 100 mg TOPICAL OTC Monograph Drug 11 sections
POVIDONE-IODINE HUMAN OTC DRUG LABEL 1 0924-5408 SOLUTION 10 mg TOPICAL OTC Monograph Drug 11 sections
First Aid Only Povidone-Iodine Prep Pad HUMAN OTC DRUG LABEL 1 0924-8110 PATCH 10 g TOPICAL OTC Monograph Drug 9 sections
First Aid Only Povidone-Iodine Antiseptic HUMAN OTC DRUG LABEL 1 0924-8113 PATCH 10 g TOPICAL OTC Monograph Drug 12 sections
Povidone-Iodine Swabstick HUMAN OTC DRUG LABEL 1 10819-3800 STICK 10 mg TOPICAL OTC Monograph Drug 10 sections
Povidone-Iodine Swabstick HUMAN OTC DRUG LABEL 1 10819-3800 STICK 10 mg TOPICAL OTC Monograph Drug 10 sections
PVP Iodine Prep PadMedium and Large HUMAN OTC DRUG LABEL 1 10819-3883 SWAB 10 mg TOPICAL OTC Monograph Drug 11 sections
PVP Iodine Prep PadMedium and Large HUMAN OTC DRUG LABEL 1 10819-3883 SWAB 10 mg TOPICAL OTC Monograph Drug 11 sections
PVP Iodine Prep SwabstickOnes and Threes HUMAN OTC DRUG LABEL 1 10819-3885 STICK 10 mg TOPICAL OTC Monograph Drug 11 sections
PVP Iodine Prep SwabstickOnes and Threes HUMAN OTC DRUG LABEL 1 10819-3885 STICK 10 mg TOPICAL OTC Monograph Drug 11 sections
Profend Nasal Decolonization HUMAN OTC DRUG LABEL 1 10819-3888 SWAB 10 mg TOPICAL OTC Monograph Drug 10 sections
Profend Nasal Antiseptic Kit HUMAN OTC DRUG LABEL 1 10819-3889 SWAB 10 mg TOPICAL OTC Monograph Drug 10 sections